Concepedia

W.W. ten Bokkel Huinink

WT

100

Publications

7.7K

Citations

47

H-Index

1983

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Slotervaartziekenhuis

Utrecht University

University of Amsterdam

W.W. ten Bokkel Huinink is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1983–2009

100

Publications

100

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 640 citations

Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918

C.M.F. Kruijtzer, Jos H. Beijnen, Hilde Rosing et al. · Journal of Clinical Oncology · 2002 · 456 citations

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt‐Dusebout, Janine Nuver, Ronald de Wit et al. · Journal of Clinical Oncology · 2006 · 349 citations · Full text

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

Manon Huizing, Anther Keung, Hilde Rosing et al. · Journal of Clinical Oncology · 1993 · 311 citations

Rows per page

1–5 of 100